M Kletzel
Overview
Explore the profile of M Kletzel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
333
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Curi D, Duerst R, Badke C, Bell J, Chaudhury S, Kletzel M, et al.
Bone Marrow Transplant
. 2016 May;
51(10):1394-1396.
PMID: 27214074
No abstract available.
2.
Hale G, Arora M, Ahn K, He W, Camitta B, Bishop M, et al.
Bone Marrow Transplant
. 2013 Feb;
48(8):1056-64.
PMID: 23419433
Although the role of autologous hematopoietic cell transplantation (auto-HCT) is well established in neuroblastoma (NBL), the role of allogeneic HCT (allo-HCT) is controversial. The Center for International Blood and Marrow...
3.
Seif A, Naranjo A, Baker D, Bunin N, Kletzel M, Kretschmar C, et al.
Bone Marrow Transplant
. 2013 Jan;
48(7):947-52.
PMID: 23334272
Increasing treatment intensity has improved outcomes for children with neuroblastoma. We performed a pilot study in the Children's Oncology Group to assess the feasibility and toxicity of a tandem myeloablative...
4.
Chaudhury S, Hormaza L, Mohammad S, Lokar J, Ekong U, Alonso E, et al.
Am J Transplant
. 2012 Mar;
12(6):1627-31.
PMID: 22405037
Mevalonic aciduria because of mutations of the gene for mevalonate kinase causes limited synthesis of isoprenoids, the effects of which are widespread. The outcome for affected children is poor. A...
5.
Thakar M, Kurre P, Storb R, Kletzel M, Frangoul H, Pulsipher M, et al.
Bone Marrow Transplant
. 2010 Jun;
46(4):539-44.
PMID: 20581880
A nonmyeloablative conditioning regimen consisting of fludarabine (FLU) and 2 Gy TBI has been used extensively and with substantial engraftment success without promoting excessive nonrelapse mortality in medically infirm patients...
6.
Kletzel M, Haut P, Olzewski M, Figuerres E
Cytotherapy
. 2010 May;
1(5):417-22.
PMID: 20443234
Background: Animal studies performed on mice have shown that the number of cells infused following ablative regimens affected the speed and quality of engraftment. Similar studies on humans have resulted...
7.
Tse W, Duerst R, Schneiderman J, Chaudhury S, Jacobsohn D, Kletzel M
Bone Marrow Transplant
. 2009 Feb;
44(3):145-56.
PMID: 19182832
We studied the pharmacokinetic (PK) profile of single daily dose i.v. BU in children who underwent reduced-intensity conditioning (RIC) transplantation. A cohort of 19 patients < or =4 years of...
8.
Browning B, Thormann K, Seshadri R, Duerst R, Kletzel M, Jacobsohn D
Bone Marrow Transplant
. 2006 Jan;
37(5):527-33.
PMID: 16435019
Weight loss and malnutrition are major problems in patients with chronic graft-versus-host disease (GVHD). In adults, low body mass index (BMI) is a predictor for mortality; however, weight loss and...
9.
Kletzel M, Pirich L, Haut P, Cohn R
Pediatr Transplant
. 2005 Sep;
9(5):584-8.
PMID: 16176414
We compared the results of Tc-99 evaluation of glomerular filtration rate (GFR) vs. the calculation of the creatinine clearance (CCrC) as a predictor for the development of renal insufficiency in...
10.
Olszewski M, Huang W, Chou P, Duerst R, Kletzel M
Cytotherapy
. 2005 Jul;
7(1):57-61.
PMID: 16040384
Background: Wilms' tumor 1 (WT1) gene expression is seen in a significant number of cases of human neoplasia; however, the mechanism of action remains to be clarified. We hypothesized that...